Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Natus Medical Incorporated, often referred to simply as Natus, is a leading provider in the medical, precision, and optical instruments sector, headquartered in the United States. Founded in 1989, the company has established itself as a key player in the development of innovative solutions for newborn care, neurology, and hearing assessment.
With a strong presence in North America, Europe, and Asia, Natus offers a diverse range of core products, including advanced diagnostic equipment and monitoring systems. Their commitment to quality and precision sets them apart in the industry, ensuring optimal patient outcomes. Notable achievements include a robust portfolio of patented technologies that enhance clinical efficiency and patient safety. Natus continues to solidify its market position through ongoing research and development, making significant contributions to the healthcare landscape.
-2 vs industry average
Natus Medical Incorporated’s score of 30 is lower than 48% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Natus Medical Incorporated, a US-headquartered company in the Medical, precision and optical instruments, watches and clocks industry, reported total carbon emissions of approximately 99.25 million kg CO2e in 2024. This included about 6.38 million kg CO2e from Scope 1 emissions, 4.055 million kg CO2e from Scope 2 emissions, and 88.82 million kg CO2e from Scope 3 emissions.
In 2023, the company's total emissions were approximately 16.44 million kg CO2e, comprising about 245,000 kg CO2e from Scope 1, 432,000 kg CO2e from Scope 2, and 15.76 million kg CO2e from Scope 3. For 2022, Natus Medical Incorporated disclosed Scope 1 emissions of approximately 404,000 kg CO2e and Scope 2 emissions of about 282,600 kg CO2e. In 2021, only Scope 1 emissions were reported, totalling approximately 533 million kg CO2e.
Natus Medical Incorporated has set a near-term, absolute reduction target aligned with the Science Based Targets initiative (SBTi). The company aims to reduce its carbon emissions by 12.5% to 22,000 tonnes CO2e by 2028, using 2023 as the base year. This target covers all scopes of emissions.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more